Dupilumab for treating severe asthma with type 2 inflammation
Technology appraisal guidance
Reference number: TA751
Published:
Following the end of the consultation on the appraisal consultation document, we would like to inform you that the next committee meeting for the above technology appraisal is scheduled to take place on Thursday 9 September 2021.